Items per page
1 - 60 of 60
Title Published in Access level OA Policy Year Views Downloads
Rituximab‐to‐vaccine interval on SARS‐CoV‐2 immunogenicity in children : The potential role of prior natural infectionPediatric allergy and immunology
accessLevelPublic
2024 38 12
Mise à jour des vaccins chez les personnes âgéesRevue médicale suisse
accessLevelRestricted
2024 28 0
Influence of timing of maternal pertussis immunization on the avidity of transferred antibodies in term and preterm neonatesClinical infectious diseases
accessLevelPublic
2023 27 12
Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19Frontiers in immunology
accessLevelPublic
2023 141 18
High-throughput spatiotemporal monitoring of single-cell secretions via plasmonic microwell arraysNature biomedical engineering
accessLevelPublic
2023 71 77
COVID-19 Vaccine Development - where do we stand?
accessLevelRestricted
2022 235 15
Omicron-specific cytotoxic t-cell responses after a third dose of mrna covid-19 vaccine among patients with multiple sclerosis treated with ocrelizumabJAMA neurology
accessLevelPublic
2022 175 99
Adjuvanted recombinant zoster vaccine in solid organ transplant and hematopoietic stem-cell transplant recipientsCurrent opinion in infectious diseases
accessLevelPublic
2022 36 111
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 yearsScientific reports
accessLevelPublic
2022 81 13
Gynécologie-obstétrique - Grossesse et Covid-19 : recommandations médicamenteuses et vaccinales en 2021Revue médicale suisse
accessLevelPublic
2022 50 21
A comparison of Sars-Cov-2 vaccine platforms : the CoviCompare projectNature medicine
accessLevelPublic
2022 34 31
Transient elevation of humoral responses against apolipoprotein A-1 following COVID-19 and its association with symptoms persistence90th EAS (European Atherosclerosis Society) Congress
2022 61 0
Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not BetaNature
accessLevelPublic
2022 1,371 185
Robust T-Cell Responses in Anti-CD20 Treated Patients Following COVID-19 Vaccination: A Prospective Cohort StudyClinical infectious diseases
accessLevelPublic
2022 154 27
Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistenceEuropean journal of clinical investigation
accessLevelPublic
2022 358 75
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCsNature communications
accessLevelPublic
2022 217 113
T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipientsAnnals of oncology
accessLevelPublic
2022 123 39
Contrasting behavior between the three human monocyte subsets in dengue pathophysiologyiScience
accessLevelPublic
2022 51 14
Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive AnalysisFrontiers in immunology
accessLevelPublic
2022 137 54
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation : An updated EASL position paperJournal of hepatology
accessLevelPublic
2022 28 39
Is there a role for childhood vaccination against COVID-19?Pediatric allergy and immunology
accessLevelRestricted
2021 213 1
Maladies infectieusesRevue médicale suisse
accessLevelPublic
2021 311 79
SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1EAS Congress 2021
2021 251 38
Defining HPV-specific B cell responses in patients with head and neck cancerNature
accessLevelRestricted
2021 69 0
The Potential Role of Nonhuman Primate Models to Better Comprehend Early Life Immunity and Maternal Antibody TransferVaccines
accessLevelPublic
2021 70 49
Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunityCell reports
accessLevelPublic
2021 332 164
Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infectionClinical Microbiology and Infection
accessLevelPublic
2021 460 262
Vaccination against Cancer or Infectious Agents during Checkpoint Inhibitor TherapyVaccines
accessLevelPublic
2021 37 64
Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of SymptomsJournal of clinical immunology
accessLevelPublic
2021 232 83
Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipientsBone marrow transplantation
accessLevelRestricted
2021 227 2
Influenza Immunization in the Context of Preexisting ImmunityCold Spring Harbor perspectives in medicine
accessLevelPublic
2021 29 8
Coronavirus disease 2019 vaccination in transplant recipientsCurrent opinion in infectious diseases
accessLevelRestricted
2021 69 0
Immunological assessment of pediatric multisystem inflammatory syndrome related to COVID-19Journal of the Pediatric Infectious Diseases Society
accessLevelPublic
2021 268 27
Paradoxes and Uncertainties of Immunomodulatory Treatments in the Fight Against Coronavirus Disease 2019Clinical infectious diseases
accessLevelPublic
2021 146 41
Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal studyClinical Microbiology and Infection
accessLevelPublic
2021 340 165
SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1European Journal of Clinical Investigation
accessLevelPublic
2021 306 206
Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivityClinical microbiology and infection
accessLevelRestricted
2021 645 0
Faudra-t-il vacciner les enfants contre le Covid-19 ?Revue médicale suisse
accessLevelPublic
2021 54 21
EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipientsJournal of hepatology
accessLevelPublic
2021 46 66
Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancerNature
accessLevelRestricted
2021 71 0
Protected or not protected, that is the question - First data on COVID-19 vaccine responses in patients with NAFLD and liver transplant recipientsJournal of hepatology
accessLevelPublic
2021 77 46
Multi-stage group testing improves efficiency of large-scale COVID-19 screeningJournal of Clinical Virology
accessLevelRestricted
2020 266 0
Persistence of varicella-zoster virus-specific plasma cells in adult human bone marrow following childhood vaccinationJournal of Virology
accessLevelRestricted
2020 365 0
Challenges and issues of SARS-CoV-2 pool testingThe Lancet Infectious Diseases
accessLevelRestricted
2020 278 4
Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case seriesmSphere
accessLevelPublic
2020 432 170
Maternal antibodies inhibit neonatal and infant responses to vaccination by shaping the early-life B cell repertoire within germinal centersCell Reports
accessLevelPublic
2019 242 145
Does Maternal Tdap Vaccination During Pregnancy Increase the Risk of Developing Chorioamnionitis? - A Monocentric, Retrospective, Observational Study
accessLevelRestricted
2019 70 4
Characterization of virus-specific immune response during varicella zoster virus encephalitis in a young adultClinical Infectious Diseases
accessLevelRestricted
2019 257 0
Understanding the immunology of the Zostavax shingles vaccineCurrent Opinion in Immunology
accessLevelRestricted
2019 234 0
Overcoming the neonatal limitations of inducing germinal centers through liposome-based adjuvants including c-type lectin agonists trehalose dibehenate or curdlanFrontiers in Immunology
accessLevelPublic
2018 429 399
Review of maternal immunisation during pregnancy: focus on pertussis and influenzaSwiss Medical Weekly
accessLevelPublic
2017 299 114
Pertussis Antibody Transfer to Preterm Neonates After Second- Versus Third-Trimester Maternal ImmunizationClinical Infectious Diseases
accessLevelPublic
2017 575 224
Antenatal vaccination to decrease pertussis in infants: safety, effectiveness, timing, and implementationThe Journal of Maternal - Fetal & Neonatal Medicine
accessLevelRestricted
2017 420 0
Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussisClinical infectious diseases
accessLevelRestricted
2016 670 5
Recommandations de vaccination chez la femme enceinte : une piqûre de rappelRevue médicale suisse
accessLevelRestricted
2016 373 2
Reply to Abu Raya et alClinical infectious diseases
accessLevelRestricted
2016 401 3
MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early LifeThe Journal of immunology
accessLevelRestricted
2015 570 2
Needle-free and adjuvant-free epicutaneous boosting of pertussis immunity: Preclinical proof of conceptVaccine
accessLevelPublic
2015 580 130
The Seatbelt Syndrome-Do We Have a Chance?: A Report of 3 Cases With Review of LiteraturePediatric emergency care
accessLevelRestricted
2015 511 2
Cholestasis as the leading sign of a transmesenteric hernia in a split-liver transplanted child - a case report and review of literaturePediatric transplantation
accessLevelRestricted
2012 605 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack